SGS will double Illinois facility capacity with proposed expansion

The bio/pharmaceutical analytical and bioanalytical contract solutions provider, SGS, has announced it is expanding its facility based in Lincolnshire, Chicago.

This expansion will see the Illinois-based facility increase capacity by 50% and is expected to be completed in September this year.

“This investment allows us to be flexible in our approach to meeting both existing and future customer demands,” commented James Nokes, vice president, US Agriculture, Food and Life. “Analysis and bioanalysis techniques continue to evolve rapidly, and are driven by technological advances and regulatory needs. At SGS, it is our aim to ensure we can offer our clients integrated solutions to support their needs, so we continue to invest in capabilities, capacity and our staff to maintain our professionalism and efficiency.”

The expansion will afford an increased capacity for the various services offered by SGS, including analytical method development and testing, microbiological evaluation, drug stability studies, testing of containers and medical devices, and utilities qualification and monitoring. Additional staff will also be employed to meet the increased demands on the laboratory.